Tumor biology
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Tumor biology
Jul 22, 2024, 20:26 |
Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jun 28, 2024, 05:37 |
Blog
Istvan Petak: Pleasure to give a talk at the Drug Development Course 2024
Istvan Petak shared on LinkedIn: “Hello, amazing Switzerland, beautiful Bellinzona. It was a pleasure to…
Jun 18, 2024, 17:53 |
Blog
Sabine D. Brookman-May: Older patients with NMIBC show more aggressive tumors
Sabine D. Brookman-May, Professor of Urology at Ludwig-Maximilians University, shared a post by Niyati Lobo, Consultant…
Jun 15, 2024, 01:18 |
Blog
Karen Knudsen: All in against cancer with my friends from Coaches vs. Cancer
Karen Knudsen shared on LinkedIn: “All in against cancer with my friends from Coaches vs. Cancer…
Jun 4, 2024, 09:59 |
Blog
Marco Gymnopoulos: Looking for an associate director for my solid tumor ADC portfolio team at AstraZeneca
Marco Gymnopoulos, Director ADC Portfolio at AstraZeneca, shared a post on LinkedIn: ''Hiring: I am…
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 22, 2024, 13:20 |
Blog
Adam MacLean: A new Neu - a syngeneic model of spontaneously metastatic HER2‑positive breast cancer
Adam MacLean, Assistant Professor at University of Southern California, made the following post on X:…
May 3, 2024, 04:36 |
Blog
Grand rounds lecture from Dr. Chris Booth and Bishal Gyawali - Common Sense Oncology
Common Sense Oncology shared on X/Twitter: "As a primer on CSO, here is a record of…
Apr 12, 2024, 08:11 |
Blog
Angela Mastronuzzi: The necessity to adopt the new classification when considering therapeutic options
Angela Mastronuzzi shared a post on LinkedIn: "Our recently published paper is out with Frontiers!…
Jan 12, 2024, 21:53 |
Opinion
Yüksel Ürün: Exploring the next generation of antibody–drug conjugates
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Oct 26, 2023, 09:27 |
Opinion
Maurizio Scaltriti: What stands out at ESMO23 is the critical role that innovative trial design, early mechanistic studies and ongoing translational analysis play in informing treatment strategy
Aug 17, 2023, 16:27 |
Insight
Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.
Arndt Vogel has recently shared 0n Twitter: ''Next batter up! Targeting cancers with KRAS-G12D mutations…
All:
12
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube